Skip to main content
SpringerLink
Log in

Regionale Chemotherapie zur Prävention oder Palliation von Lebermetastasen colorectaler Carcinome

  • Chapter
Colorectales Carcinom

Part of the book series: Onkologie heute ((ONKOLOGIE))

  • 17 Accesses

Zusammenfassung

Die Leber ist jenes Organ, das am häufigsten von Metastasen colorectalen Ursprungs betroffen ist (Pickren et al. 1989). 10 bis 15% der Patienten weisen bereits zum Zeitpunkt der Diagnose des Primärtumors metastatische Absiedelungen in der Leber auf (Yomanaka et al. 1984, Egglin et al. 1990, Sitzmann et al. 1990), und es stellt dies die häufigste Todesursache bei dieser Tumorentität dar.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 39.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adson MA, van Heerden JA, et al. (1984) Resection of hepatic metastases from colorectal cancer. Arch Surg 119(6): 647–651.

    Article  PubMed  CAS  Google Scholar 

  2. Allen-Mersh TG, Earlam S, et al. (1994) Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344(8932): 1255–1260.

    Article  PubMed  CAS  Google Scholar 

  3. Ariel IM (1972) Hepatic metastases from rectal and colon cancers. NY State J Med 72: 2629–2632.

    CAS  Google Scholar 

  4. Ariel IM, Padula G (1978a) Treatment of symptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intra-arterial administration of chemotherapy and radioactive isotopes. Prog Clin Cancer 7: 247–254.

    PubMed  CAS  Google Scholar 

  5. Ariel IM, Padula G (1978b) Treatment of symptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intra-arterial administration of chemotherapy and radioactive isotopes. J Surg Oncol 10: 327–336.

    Article  PubMed  CAS  Google Scholar 

  6. Asahara T, Kikkawa M, et al. (1998) Studies of postoperative transarterial infusion chemotherapy for liver metastasis of colorectal carcinoma after hepatectomy. Hepatogastroenterology 45(21): 805–811.

    PubMed  CAS  Google Scholar 

  7. Bakalakos EA, Kim JA, et al. (1998) Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg 22(4): 399–404.

    Article  PubMed  CAS  Google Scholar 

  8. Bavisotto LM, Patel NH, et al. (1999) Hepatic transcatheter arterial chemoemboliza-tion alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: A phase II trail of Puget Sound Oncology Consortium. Clin Cancer Res 5(1): 95–109.

    PubMed  CAS  Google Scholar 

  9. Beart RW, Moertel CG, et al. (1990) Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vain infusion. Arch Surch 125: 897–901.

    Article  Google Scholar 

  10. Bismuth H, Adam R, et al. (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224(4): 509–520.

    Article  PubMed  CAS  Google Scholar 

  11. Blackshear PJ, Dorman FD, et al. (1972) The design and initial testing of an implantable infusion pump. Surg Gynecol Obstet 134(1): 51–56.

    PubMed  CAS  Google Scholar 

  12. Breedes C, Young G (1954) The blood supply of neoplasms in the liver. Am J Pathol 30: 227.

    Google Scholar 

  13. Buchwald H, Grage TB, et al. (1980) Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 45(5): 866–869.

    Article  PubMed  CAS  Google Scholar 

  14. Buyse M (1996) Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88: 252–258.

    Article  Google Scholar 

  15. Carrasco CH, Freeny PC, et al. (1983) Chemical cholecystitis associated with hepatic artery infusion chemotherapy. AJR 141: 703–706.

    PubMed  CAS  Google Scholar 

  16. Chang AE, Schneider PD, et al. (1987) A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206(6): 685–693.

    Article  PubMed  CAS  Google Scholar 

  17. Chuang VP, Wallace S, et al. (1982) Therapeutic Ivalon embolisation of hepatic tumors. Am J Roengenol 138: 289–294.

    CAS  Google Scholar 

  18. Chuang VP, Wallance S, et al. (1981) Hepatic artery infusion chemotherapy: Gastroduodenal complications. Am J Radil 137: 347.

    CAS  Google Scholar 

  19. Cohen AM, Schaeffer N, et al. (1986) Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy. Cancer 57(6): 1115–1117.

    Article  PubMed  CAS  Google Scholar 

  20. Cohen RJ, Minor DR, et al. (1990) Treatment of refractory cancer by intravenous in-terleukin-2 (IL-2) together with lymphokine-activated killer (LAK) cells administered by direct regional infusion. Pros Am Soc Clin Oncol 9: A748.

    Google Scholar 

  21. Collins JM (1990) Pharmacokinetics and clinical monitoring. In: Chabner BA, Collins JM (eds.) Cancer Chemotherapy, Principles and Practice. JB Lippincott, Philadelphia.

    Google Scholar 

  22. Copeland EM, Miller LD, et al. (1968) Prognostic factors in carcinoma of the colon and rectum. Am J Surg 116(6): 875–881.

    Article  PubMed  CAS  Google Scholar 

  23. Curley SA, Roh MS, et al. (1993) Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg 166(6): 743–746; discussion 746–748.

    Article  PubMed  CAS  Google Scholar 

  24. Daly JM, Kemeny N, et al. (1987) Regional infusion for colorectal hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein. Arch Surg 122(11): 1273–1277.

    Article  PubMed  CAS  Google Scholar 

  25. Doria Jr MI, Shepard KV, et al. (1986) Liver pathology following hepatic arterial infusion chemotherapy. Hepatic toxicity with FUDR. Cancer 58(4): 855–861.

    Article  PubMed  Google Scholar 

  26. Earlam S, Glover C, et al. (1997) Effect of regional and systemic fluorinated pyrim-idine chemotherapy on quality of life in colorectal liver metastasis patients. J Clin Oncol 15(5): 2022–2029.

    PubMed  CAS  Google Scholar 

  27. Egglin TK, Rummeny E, et al. (1990) Hepatic tumors: Quantitative tissue characterization with MR imaging. Radiology 176(1): 107–110.

    PubMed  CAS  Google Scholar 

  28. Elias D, Cavalcanti A, et al. (1998) Resection of liver metastases from colorectal cancer: The real impact of the surgical margin. Eur J Surg Oncol 24(3): 174–179.

    Article  PubMed  CAS  Google Scholar 

  29. Ensminger W, Niederhuber J, et al. (1981) Totally implanted drug delivery system for hepatic arterial chemotherapy. Cancer Treat Rep 65(5–6): 393–400.

    PubMed  CAS  Google Scholar 

  30. Ensminger W, Niederhuber J, et al. (1982) Effective control of liver metastases from colon cancer with an implanted system for hepatic arterial chemotherapy. Proc Am Soc Clin Oncol 1:A94.

    Google Scholar 

  31. Ensminger WD, Gyves JW (1984) Regional cancer chemotherapy. Cancer Treat Rep 68(1): 101–115.

    PubMed  CAS  Google Scholar 

  32. Ensminger WD, Rosowsky A, et al. (1978) A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil. Cancer Res 38 (11 Pt 1): 3784–3792.

    PubMed  CAS  Google Scholar 

  33. Fisher ER, Turnbull RBJ (1955) The cytologic demonstration and significance of tumor cells in the mesenterie venous blood in patients with colorectal carcinoma. Surg Gynecol Obster 100: 102–108.

    CAS  Google Scholar 

  34. Fortner JG, Silva JS, et al. (1984a) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 199(3): 306–316.

    Article  PubMed  CAS  Google Scholar 

  35. Fortner JG, Silva JS, et al. (1984b) Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy. Ann Surg 199(3): 317–324.

    Article  PubMed  CAS  Google Scholar 

  36. Foster JH, Lundy J (1981) Liver Metastases. Curr Probi Surg 18(3): 157–202.

    Article  CAS  Google Scholar 

  37. Gray BN, de Zwart J, et al. (1987) The Australian and New Zealand trial of adjuvant chemotherapy in colon cancer. In: Salmon SE (ed) Adjuvant of Cancer V, S. 537–554. Grune & Stratton, New York.

    Google Scholar 

  38. Hafstrom L, Naredi P (1998) Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia TNF alpha and melphalan: Swedish experience. Recent Results Cancer Res 147: 120–126.

    Article  PubMed  CAS  Google Scholar 

  39. Hanazaki K, Kawamura N, et al. (1998) Long-term survivor with liver metastases from rectal cancer treated by hepatectomy after hepatic arterial infusion chemotherapy. Hepatogastroenterology 45(21): 816–820.

    PubMed  CAS  Google Scholar 

  40. Hartmann JT, Schmoll E, et al. (1998) Phase I pharmacological study of intra-arteri-ally infused fotemustine for colorectal liver metastases. Eur J Cancer 34(1): 87–91.

    Article  PubMed  CAS  Google Scholar 

  41. Hohn D (1987) A phase I-II trial of gelfoam chemoembolization in patients with primary liver tumors. Proc ASCO 6.

    Google Scholar 

  42. Hohn D, Melnick J, et al. (1985) Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol 3(1): 98–102.

    PubMed  CAS  Google Scholar 

  43. Hohn DC, Rayner AA, et al. (1986) Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 57(3): 465–470.

    Article  PubMed  CAS  Google Scholar 

  44. Hohn DC, Shea WJ, et al. (1988) Complications and toxicities of hepatic arterial chemotherapy. Contr Oncol 29: 169–180.

    Google Scholar 

  45. Hohn DC, Stagg RJ, et al. (1989) A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial. J Clin Oncol 7(11): 1646–1654.

    PubMed  CAS  Google Scholar 

  46. Howell JD, McArdle CS, et al. (1997) A phase II study of regional 2-weekly 5-flu-orouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases. Br J Cancer 76(10): 1390–1393.

    Article  PubMed  CAS  Google Scholar 

  47. Hubermann MS (1983) Comparison of systemic chemotherapy with hepatic arterial infusion in metastatic colorectal carcinoma. Semin Oncol 10: 238–248.

    Google Scholar 

  48. Hughes K, Scheele J, et al. (1989) Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am 69(2): 339–359.

    CAS  Google Scholar 

  49. Jaeck D, Bachellier P, et al. (1997) Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg 84(7): 977–980.

    Article  PubMed  CAS  Google Scholar 

  50. Kemeny MM, Goldberg DA, et al. (1985) Experience with continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. A prospective randomized study. Cancer 55(6): 1265–1270.

    CAS  Google Scholar 

  51. Kemeny N, Conti JA, et al. (1994) Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 12(11): 2288–2295.

    PubMed  CAS  Google Scholar 

  52. Kemeny N, Daly J, et al. (1984) Hepatic artery pump infusion: Toxicity and results in patients with metastatic colorectal carcinoma. J Clin Oncol 2(6): 595–600.

    PubMed  CAS  Google Scholar 

  53. Kemeny N, Daly J, et al. (1987) Intrahepatic or systemic infusion of fluorodeoxyuri-dine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 107: 459–465.

    PubMed  CAS  Google Scholar 

  54. Kemeny N, Daly J, et al. (1987) Intrahepatic or systemic infusion of fluorodeoxyuri-dine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 107(4): 459–465.

    CAS  Google Scholar 

  55. Kemeny N, Lokich JJ, et al. (1993) Recent advances in the treatment of advanced colorectal cancer. Cancer 71(1): 9–18.

    Article  PubMed  CAS  Google Scholar 

  56. Kemeny N, Schneider A (1989) Regional treatment of hepatic metastases and hepatocellular carcinoma. Curr Probi Cancer 13(4): 197–283.

    CAS  Google Scholar 

  57. Kemeny N, Seiter K, et al. (1992) A randomized trial of intrahepatic infusion of flu-orodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 69(2): 327–334.

    Article  PubMed  CAS  Google Scholar 

  58. Klasa RJ, Silver HKB (1989) Phase 1–2 trial of interleukin-2 (IL-2) splenic artery perfusion in advanced malignancy. Eur J Cancer Clin Oncol 25: 379–388.

    Article  Google Scholar 

  59. Laffer U, Metzger U, et al. (1990) Randomized multicenter trial on adjuvant intraportal chemotherapy for colorectal cancer (SAKK 40/81). In: Jakesz R, Rainer H (eds.) Progress in Regional Cancer Therapy, S. 31–40. Springer, Berlin, Heidelberg, New York.

    Chapter  Google Scholar 

  60. Latham LJ, Foster JH (1967) Hepatic resection for metastatic cancer. Am J Surg 113: 51–557.

    Google Scholar 

  61. Link KH, Aigner KR, et al. (1987) In vitro chemosensitivity profiles of human malignancies for high dose (regional) chemotherapy. In: Aigner KR, Patt YZ (eds.) Regional Cancer Treatment, Contributions to Oncology. Karger, Basel.

    Google Scholar 

  62. Link KH, Kreuser ED, et al. (1993) Die intraarterielle Chemotherapie mit 5-FU und Folinsäure (FA, Rescuvolin) im Therapiekonzept bei nicht resektablen colorectalen Lebermetastasen. Tumordign Ther 14: 224–231.

    Google Scholar 

  63. Lorenz M, Muller HH, et al. (1998) Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 228(6): 756–762.

    Article  PubMed  CAS  Google Scholar 

  64. Lorenz M, Staib-Sebler E, et al. (1998) A pilot study on intensive weekly 24-hour intra-arterial infusion with 5-fluorouracil and folinic acid for colorectal liver metastases. Oncology 55(1): 53–58.

    Article  PubMed  CAS  Google Scholar 

  65. Machover D, Goldschmidt E, et al. (1986) Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 4(5): 685–696.

    PubMed  CAS  Google Scholar 

  66. Martin JKJ, O’Connell MJ, et al. (1990) Intra-arterial floxuridine versus systemic flu-orouracil for hepatic metastases from colorectal cancer: A randomized trial. Arch Surg 125: 1022–1027.

    Article  PubMed  Google Scholar 

  67. Mavligit GM, Zukiwski AA, et al. (1992) Regional biologic therapy. Hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastases. Cancer 69(2): 557–561.

    Article  PubMed  CAS  Google Scholar 

  68. Medenica R, Huschart T (1991 ) Intraarterial/intrahepatic therapy regimen using phar-macosensitivity model in vitro. Proc Am Soc Clin Oncol 10: A456.

    Google Scholar 

  69. Meta-Analyse (1997) Portal vein chemotherapy for colorectal cancer: A meta-analysis of 4000 patients in 10 studies. Liver Infusion Meta-Analysis Group. J Natl Cancer Inst 89(7): 497–505.

    Google Scholar 

  70. Metzger U (1988) Intraportal chemotherapy for colorectal hepatic metastases. Antibiot Chemother 40: 51–60.

    PubMed  CAS  Google Scholar 

  71. Metzger U, Laffer U, et al. (1989) Adjuvant intraportal chemotherapy for colorectal cancer: 4 year results of the randomized Swiss study. Proc Am Soc Clin Oncol 8: 105.

    Google Scholar 

  72. Metzger U, Mermillod B, et al. (1987) Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality. World J Surg 11(4): 452–458.

    Article  PubMed  CAS  Google Scholar 

  73. Narsete T, Ansfield F, et al. (1977) Gastric ulceration in patients receiving intrahepatic infusion of 5-fluorouracil. Ann Surg 186(6): 734–736.

    Article  PubMed  CAS  Google Scholar 

  74. Niederhuber JE, Ensminger W, et al. (1984) Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 53(6): 1336–1343.

    Article  PubMed  CAS  Google Scholar 

  75. Niederhuber JE, Ensminger WD (1983) Surgical considerations in the management of hepatic neoplasia. Semin Oncol 10(2): 135–147.

    PubMed  CAS  Google Scholar 

  76. Niederhuber JE, Grochow LB (1989) Status of infusion chemotherapy for the treatment of liver metastases. Principles and Practice of Oncology (Updates) 3(3): 1–9.

    Google Scholar 

  77. Northover JM, Terblanche J (1979) A new look at the arterial supply of the bile duct in man and its surgical implications. Br J Surg 66(6): 379–384.

    Article  PubMed  CAS  Google Scholar 

  78. O’Connell MJ, Nagorney DM, et al. (1998) Sequential intrahepatic fluorodexyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confines to the liver. J Clin Oncol 16(7): 2528–2533.

    PubMed  Google Scholar 

  79. Oberfield RA, McCaffrey JA, et al. (1979) Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer 44(2): 414–423.

    Article  PubMed  CAS  Google Scholar 

  80. Okuno K, Hirohata T, et al. (1993) Hepatic arterial infusions of interleukin-2-based immunochemotherapy in the treatment of unresectable liver metastases from colorectal cancer. Clin Ther 15(4): 672–683.

    PubMed  CAS  Google Scholar 

  81. Okuno K, Kobayashi S, et al. (1996) IL-2 percusion to the liver augments the hepatic extraction rate of accompanying anticancer drugs. Surg Today 26(8): 662–664.

    Article  PubMed  CAS  Google Scholar 

  82. Okuno K, Nakamura K, et al. (1998) Hepatic immunopotentiation by galactose-en-trapped liposomal IL-2 compound in the treatment of liver metastases. Surg Today 28(1): 64–69.

    Article  PubMed  CAS  Google Scholar 

  83. Okuno K, Ohnishi H, et al. (1994) Complete remission of liver metastases from colorectal cancer by treatment with a hepatic artery infusion (HAI) of interleukin-2-based immunochemotherapy: Reports of three cases. Surg Today 24(1): 80–84.

    Article  PubMed  CAS  Google Scholar 

  84. Okuno K, Ohnishi H, et al. (1992) Intrahepatic infusion of interleukin-2 (IL-2) with mitomycin C (MMC)/5-fluorouracil (5-FU) through an implantable pump for the treatment of liver metastases. Proc Am Ass Cancer Res 33: A1475.

    Google Scholar 

  85. Okuno K, Shigeoka H, et al. (1996) Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases. Hepatogastroenterology 43(9): 688–691.

    PubMed  CAS  Google Scholar 

  86. Okuno K, Yasutomi M, et al. (1998) Longterm effects of hepatic arterial interleukin-2-based immunochemotherapy after potentially curative resection of colorectal liver metastases. J Am Coll Surg 187(3): 271–275.

    Article  PubMed  CAS  Google Scholar 

  87. Patt YZ, Chuang VP, et al. (1983) Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver. Cancer 51(8): 1359–1363

    Article  PubMed  CAS  Google Scholar 

  88. Patt YZ, Hoque A, et al. (1997) Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin. J Clin Oncol 15(4): 1432–1438.

    PubMed  CAS  Google Scholar 

  89. Pestana C, Reitemeyer RJ, et al. (1964) The natural history of carcinoma of the colon and rectum. Am J Surg 108: 826–829.

    Article  PubMed  CAS  Google Scholar 

  90. Pickren JW, Houghton A, et al. (1989) Analysis of autopsy data. Liver Metastasis, S. 2–18. G.K. Hall, Boston.

    Google Scholar 

  91. Roughier PH, Jay JM, et al. (1990) A controlled multicentric trial of intrahepatic chemotherapy versus standard palliative treatment for colorectal liver metastases. Proc Am Soc Clin Oncol 9: A104.

    Google Scholar 

  92. Safi F, Bittner R, et al. (1989) Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intrave-nous therapy). Results of a controlled clinical trial. Cancer 64(2): 379–387.

    Article  PubMed  CAS  Google Scholar 

  93. Scheele J, Stangl R, et al. (1990) Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history. Br J Surg 77(11): 1241–1246.

    Article  PubMed  CAS  Google Scholar 

  94. Seiter K, Kemeny N, et al. (1991) A phase I trial of hepatic artery fluordeoxuridine combined with systemic 5-fluorouracil for the treatment of metastases from colorectal cancer. Reg Cancer Treat 3: 393–397.

    Google Scholar 

  95. Shepard KV, Levin B, et al. (1985) Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump. J Clin Oncol 3(2): 161–169.

    PubMed  CAS  Google Scholar 

  96. Sitzmann JV, Coleman J, et al. (1990) Preoperative assessment of malignant hepatic tumors. Am J Surg 159(1): 137–142; discussion 142–143.

    Article  PubMed  CAS  Google Scholar 

  97. Smiley S, Schouten J, et al. (1981) Intrahepatic arterial infusion with 5-FU for liver metastases of colorectal carcinoma. Pros Am Ass Cancer Res 22: 391.

    Google Scholar 

  98. Stagg RJ, Venook AP, et al. (1991) Alternating hepatic intra-arterial floxuridine and fluorouracil: A less toxic regimen for treatment of liver metastases from colorectal cancer. J Natl Cancer Inst 83(6): 423–428.

    Article  PubMed  CAS  Google Scholar 

  99. Stagg RJ, Venook AP, et al. (1994) Hepatic intra-arterial FUDR/5-FU therapy for patients with metastatic colorectal cancer (CRC) to the liver who have failed systemic fluoropyrimidine therapy. Proceedings of Asco 1: 217.

    Google Scholar 

  100. Steele Jr G, Bleday R, et al. (1991) A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol 9(7): 1105–1112.

    PubMed  Google Scholar 

  101. Steele Jr G, Ravikumar TS (1989) Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 210(2): 127–138.

    Article  PubMed  Google Scholar 

  102. Sullivan RD, Norcross JW, et al. (1964) Chemotherapy of metastatic liver cancer by prolonged hepatic-artery infusion. N Engl J Med 270: 321–327.

    Article  PubMed  CAS  Google Scholar 

  103. Sullivan RD, Zurek WZ (1965) Chemotherapy for liver cancer by protracted ambulatory infusion. Jama 194(5): 481–486.

    Article  PubMed  CAS  Google Scholar 

  104. Taylor I, Machin D, et al. (1985) A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg 72(5): 359–363.

    Article  PubMed  CAS  Google Scholar 

  105. Von Roemeling R, Hrushesky WJ (1990) Determination of therapeutic index of floxuridine by its circardian infusion pattern. J Natl Cancer Inst 82: 386–393.

    Article  Google Scholar 

  106. Wagner JS, Adson MA, et al. (1984) The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 199(5): 502–508.

    CAS  Google Scholar 

  107. Walther H, Kahle M, et al. (1991) Hepatic artery infusion via an implantable catheter system using the 5-fluorouracil, adriamycin, mitomycin C (FAM) chemotherapy regimen. Reg Cancer Treat 4: 136–139.

    Google Scholar 

  108. Wereldsma JC, Bruggink ED, et al. (1990) Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I). Cancer 65(3): 425–432.

    Article  PubMed  CAS  Google Scholar 

  109. Wolmark N, Rockette H, et al. (1990) Adjuvant therapy of Dukes’ A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: Preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. J Clin Oncol 8(9): 1466–1475.

    PubMed  CAS  Google Scholar 

  110. Yomanaka N, Okamoto E, et al. (1984) A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg 200: 658–663.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinische Abteilung für Onkologie, Universitätsklinik für Innere Medizin I Allgemeines Krankenhaus, Währinger Gürtel 18-20, A-1090, Wien, Österreich

    Dr. Manuela Schmidinger

Authors
  1. Dr. Manuela Schmidinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Catharina Wenzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Günther Steger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinische Abteilung für Onkologie, Univ.-Klinik für Innere Medizin I Allgemeines Krankenhaus, Wien, Österreich

    Christoph Zielinski

  2. Klinische Abteilung für Allgemeinchirurgie, Univ.-Klinik für Chirurgie Allgemeines Krankenhaus, Wien, Österreich

    Raimund Jakesz

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Wien

About this chapter

Cite this chapter

Schmidinger, M., Wenzel, C., Steger, G. (1999). Regionale Chemotherapie zur Prävention oder Palliation von Lebermetastasen colorectaler Carcinome. In: Zielinski, C., Jakesz, R. (eds) Colorectales Carcinom. Onkologie heute. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6393-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6393-1_7

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83312-4

  • Online ISBN: 978-3-7091-6393-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation